Skip to main content
. 2022 May 27;12(6):803. doi: 10.3390/life12060803

Figure 2.

Figure 2

Pleiotropic effects of SGLT2 inhibitors (adapted after [69]) (LPL: lipoprotein lipase; VLDL: very low density lipoprotein; LDL: low density lipoprotein).